Abbvie Inc. Common Stock (ABBV) 60.27 $ABBV AbbVie Inc

New Post Public Reply Private Reply Replies (0) Message Board

Mar 4, 2015 at 5:52 PM

Abbvie Inc. Common Stock (ABBV) 60.27 $ABBV

AbbVie Inc (ABBV) Downgraded From Buy to Hold
at The Street - Wed Mar 04, 9:00AM CST
AbbVie Inc (ABBV) has been downgraded by TheStreet Ratings from Buy to Hold with a ratings score of C.
ABBV: 60.27 (+0.65)

FDA imposes limits on testosterone drugs and labeling changes to warn of potential heart risks
Seeking Alpha - at Seeking Alpha - Wed Mar 04, 7:23AM CST

ENDP: 85.65 (-0.23), AUXL: 36.47 (-0.06), LPCN: 7.94 (+0.46), RPRX: 9.71 (+0.28), TEVA: 56.56 (+0.10), LLY: 70.65 (+0.28), ABBV: 60.27 (+0.65), ATRS: 2.70 (+0.05)

Pioneer Fundamental Growth Fund: Why Is It Revving Up?
at Investor's Business Daily - Tue Mar 03, 5:50PM CST
Stock mutual fund managers Andrew Acheson and Paul Cloonan have been kicking it into a higher gear at Pioneer Fundamental Growth Fund. The 16.61% average annual return of their $2.4 billion fund ranked in the top 27% of its large-cap growth rivals...
SBUX: 93.06 (-0.94), ESRX: 84.83 (+0.48), LNKD: 265.23 (-0.31), GILD: 103.06 (+0.27), ABBV: 60.27 (+0.65), AAPL: 128.54 (-0.82), CELG: 119.57 (+1.10)

Amgen: The Best Biotech Stock You Don't Own
Dan Strack - at Seeking Alpha - Tue Mar 03, 4:04PM CST

BIIB: 414.13 (+1.34), GILD: 103.06 (+0.27), PFE: 34.64 (+0.08), MRK: 57.88 (-0.46), AMGN: 159.19 (+0.63), ABBV: 60.27 (+0.65), GSK: 47.82 (+0.11), BMY: 65.67 (+3.75), HSP: 87.95 (+0.24), NVS: 99.04 (-0.02), CELG: 119.57 (+1.10)

10 Dandy Dividend Healthcare Dogs Hail 14% February Upsides
Fredrik Arnold - at Seeking Alpha - Tue Mar 03, 5:28AM CST

KND: 22.08 (-0.01), VIVO: 20.06 (+0.06), PETS: 15.08 (-0.05), PFE: 34.64 (+0.08), AMGN: 159.19 (+0.63), GSK: 47.82 (+0.11), MSA: 48.84 (-0.87), PDLI: 6.96 (-0.06), BAX: 69.25 (-0.17), AZN: 67.79 (-0.49), MRK: 57.88 (-0.46), STJ: 67.14 (-0.46), TRIB: 18.60 (+0.17), TEVA: 56.56 (+0.10), ABBV: 60.27 (+0.65), THRX: 19.64 (+0.08), SNY: 48.34 (+0.26)

The Dividend House DGI Portfolio: The Good, The Bad, And The Ugly
Dividend House - at Seeking Alpha - Mon Mar 02, 11:51PM CST

KMI: 41.04 (-0.05), ABT: 47.01 (-0.08), HAS: 62.43 (-0.29), GE: 25.66 (-0.20), MAIN: 31.12 (-0.11), HTGC: 14.46 (-0.02), TCAP: 24.60 (+0.07), DLR: 65.60 (-1.12), PFE: 34.64 (+0.08), WMT: 82.58 (-0.79), WFC: 54.82 (-0.63), UL: 43.72 (-0.33), O: 50.34 (-0.21), BMY: 65.67 (+3.75), VOD: 34.60 (-0.02), DEO: 117.00 (-0.22), TUP: 70.93 (-0.18), WTR: 26.29 (-0.16), WBA: 83.02 (-0.19), CBRL: 149.57 (-2.19), MAT: 26.38 (-0.52), OHI: 40.11 (-0.15), ABBV: 60.27 (+0.65), AFL: 62.35 (+0.07), BBL: 48.50 (-0.80), CMCSA: 60.43 (+0.47), OMI: 34.97 (-0.36)

Is Now The Time To Pounce On The Pot Business?
Nicholas Kitonyi - at Seeking Alpha - Mon Mar 02, 2:09PM CST

GWPH: 81.57 (+2.02), ABBV: 60.27 (+0.65), BMY: 65.67 (+3.75)

Bristol Myers' HCV Cocktail Has Gilead, AbbVie In Its Crosshairs
Shock Exchange - at Seeking Alpha - Mon Mar 02, 9:32AM CST

GILD: 103.06 (+0.27), ABBV: 60.27 (+0.65), BMY: 65.67 (+3.75)

These Stocks Just Raised Their Dividends
Eric Volkman, The Motley Fool - Motley Fool - Mon Mar 02, 7:03AM CST
With all the dividend raises occurring in this early part of the year, several likely suspects have decided to get in on the action. These are the Dividend Aristocrats, the companies that have raised their distributions at least once annually for a...
KO: 42.50 (-0.45), ABT: 47.01 (-0.08), ABBV: 60.27 (+0.65), CL: 70.68 (unch)

Billionaire George Soros Just Dumped These 3 Dividend Stocks
George Budwell, The Motley Fool - Motley Fool - Sun Mar 01, 9:55AM CST
Because billionaire investors can have a disproportionately large impact on how markets behave in the short term, their buys and sells tend to be closely scrutinized. And controversial hedge-fund manager George Soros is one of the most widely watched...
GILD: 103.06 (+0.27), MRK: 57.88 (-0.46), AZN: 67.79 (-0.49), TEVA: 56.56 (+0.10), ABBV: 60.27 (+0.65)

Achillion: The Dark Side
Kanak Kanti De - at Seeking Alpha - Fri Feb 27, 5:45AM CST

GILD: 103.06 (+0.27), ACHN: 11.63 (-0.51), ABBV: 60.27 (+0.65)

Cyberonics Soars On Earnings Beat, Tax Inversion Deal
at Investor's Business Daily - Thu Feb 26, 12:58PM CST
Shares of Cyberonics (CYBX) gapped up to a record high Thursday after the company reported better than expected earnings growth and said it is merging with Italy's Sorin and moving its headquarters to Europe despite new Treasury rules intended to...
ABMD: 61.24 (+1.09), QSR: 42.54 (-1.08), MDT: 78.19 (+0.16), BAX: 69.25 (-0.17), SHPG: 239.64 (+0.74), EW: 135.76 (+1.18), ABBV: 60.27 (+0.65), CYBX: 71.19 (+0.83)

Biotech Head-to-Head: Gilead vs. Celgene
Todd Campbell and Michael Douglass, The Motley Fool - Motley Fool - Thu Feb 26, 11:03AM CST
It's Fool versus Fool on this health care edition of Industry Focus. Michael Douglass argues for Gilead Sciences , while Todd Campbell goes to bat for Celgene . Which of these biotech giants is the better investment? Both companies have had...
GILD: 103.06 (+0.27), ABBV: 60.27 (+0.65), CELG: 119.57 (+1.10)

Cyberonics, Sorin Plan to Merge in Latest Tax Inversion Deal
at The Street - Thu Feb 26, 10:54AM CST
Medical device manufacturers Cyberonics and Sorin will join forces and move their headquarters to the U.K. in a deal propelled by the search for lower corporate taxes.
SHPG: 239.64 (+0.74), ABBV: 60.27 (+0.65), CYBX: 71.19 (+0.83)

New Parkinson's drug cleared in Europe
Seeking Alpha - at Seeking Alpha - Thu Feb 26, 9:23AM CST

ADMS: 17.36 (+0.11), ACOR: 35.74 (+0.54), NDRM: 13.22 (+0.74), XNPT: 7.10 (unch), IPXL: 40.40 (+0.47), ABBV: 60.27 (+0.65), TEVA: 56.56 (+0.10), SNY: 48.34 (+0.26), PRTA: 26.17 (+0.54)

FDA accepts Teva's NDA for abuse-deterrent opioid
Seeking Alpha - at Seeking Alpha - Wed Feb 25, 8:42AM CST

MNK: 116.19 (+1.34), LCI: 62.28 (+0.01), ACT: 296.14 (-0.09), EGLT: 15.36 (unch), ZGNX: 1.68 (+0.01), PFE: 34.64 (+0.08), ABBV: 60.27 (+0.65), TEVA: 56.56 (+0.10), ALKS: 70.80 (-2.00), ACUR: 0.74 (-0.08)

Updating My Price Target On Gilead Sciences
Alexander J. Poulos - at Seeking Alpha - Tue Feb 24, 12:41PM CST

JNJ: 101.65 (-0.69), ESRX: 84.83 (+0.48), GILD: 103.06 (+0.27), PFE: 34.64 (+0.08), MRK: 57.88 (-0.46), ABBV: 60.27 (+0.65)

Express Scripts Earnings Set the Stage for Growth
Todd Campbell, The Motley Fool - Motley Fool - Tue Feb 24, 10:19AM CST
Source: Express Scripts. As healthcare payers hunt for ways to rein in ever-higher drug costs, the pharmacy benefit manager Goliath Express Scripts Holding Company reported better-than-expected fourth-quarter results, and full year 2014...
ESRX: 84.83 (+0.48), UNH: 113.82 (+0.96), ABBV: 60.27 (+0.65)

AbbVie: Attractive Valuation, Growth Prospects & Yield
Bret Jensen - at Seeking Alpha - Tue Feb 24, 8:39AM CST

ABBV: 60.27 (+0.65)

Gilead: All Is Still Well Down On The Farm
Shock Exchange - at Seeking Alpha - Tue Feb 24, 7:44AM CST

GILD: 103.06 (+0.27), ABBV: 60.27 (+0.65)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Navigating New Home Builds: Tucson’s Precise Timelines

Building a Home in Tucson: Timing is Everything Ask anyone who's ever dreamed of their own custom-built home—patience isn't just a virtue, it's a necessity. In Tucson, Arizona, where the landscape is as captivating as it is challenging, Home Remodeling Expert Robin Hartman breaks down exactly what homeowners should expect when embarking on a home build. Hartman, through...

Ebix and intentyx Tackle AI Security in Regulated Fields

Ebix Aims to Rein in AI Mischief When you throw AI agents into the mix of regulated businesses like insurers, banks, and healthcare outfits, you get a storm brewing. Now, Ebix and intentyx seem to be donning their capes, aiming to bring clarity with their new SMARE security platform. Fancy name notwithstanding, this isn't about mind games—it's about real, observable...

PSEG Q3 2026: Mixed Earnings Amidst Storms and Stability

Decoding PSEG's Q3 2026 Performance A company's quarterly performance can feel a bit like checking the weather: you are never quite sure what's coming your way. For PSEG's (NYSE: PEG) third quarter of 2026, the skies were full of mixed signals. Just looking at the headline earnings number, $0.76 per share in net income, there's a drop from last year's $1.24. That’s a...

LITEON's Q3 Surge: Record Profits, AI Focus Amplified

LITEON Smashes Q3 Records, Financials Speak Volumes You don't find numbers like these under every rock. LITEON Technology is rolling in it after clinching third quarter revenues of NT$57.4 billion, marking a significant 9% growth compared to the previous quarter and a whopping 28% surge year-over-year. That's the kind of financial football that gets investors holding onto...

Nexus Capital Buys Coldwater Creek, Eyes Growth Surge

A New Chapter in Apparel Investment You know when you're flipping through those catalog pages or hitting up e-commerce sites, just to find that perfect piece of clothing for a special someone—and you stick with a brand not just outta habit, but 'cause they've got a piece of your history? That's Coldwater Creek and Soft Surroundings, two brands that's been keepin' their...

UFC Gym Expands, Opening Murfreesboro Location Soon

UFC GYM Targets the Heart of Murfreesboro They're doing it again—UFC GYM's tossing another gym into the mix, folks! This time, it's Murfreesboro, Tennessee, catching the brand's punchy, high-energy splash. Don't mistake this for just another big-box, bench-press-jamboree. Their doors swing open come November 14, and this ain't some punk move. We're talking a whopping...

Brightstar Showcases at World Lottery Summit 2026

Brightstar Aims for the Jackpot at WLS 2026 Don't kid yourself—this isn't your granddad's corner-store lottery ticket. Brightstar Lottery PLC, trading as NYSE: BRSL, is pushing the envelope at the World Lottery Summit 2026 in Sydney, flaunting a roster of high-tech and savvy solutions to meet changing player expectations. It's a collision of tradition and tech, all...

Apacer Unveils Cutting-Edge Storage at Electronica 2026

Forging New Paths in Storage Tech Technology waits for no one, and Apacer knows it better than most. At electronica 2026, they're not just tossing out buzzwords—they're backing up promises with cold hard innovations. It's like watching a seasoned chess player thinking ten moves ahead in the game that is techno-evolution. This year, they've hitched a ride on the AI,...

Zensar Sees Solid Revenue Growth in Q2FY27

Zensar's Q2 Performance: Growth Amid Shifting Sands Is Zensar Technologies quietly carving a spot for itself in the cutthroat tech marketplace, or are we just seeing a temporary glimmer during a complex market scenario? With a constant currency growth rate of 4.1% in Q2FY27, Zensar sure seems to have gotten something right. But does this mean they’ve got the long-term...

Lakeland Builds Apartments; Screening Rules Cause Snags

What's the Real Trouble in Lakeland? The Lakeland metro area surely ain't short on apartments after a colossal building frenzy. We're talking a solid 40% bump in just the past five years. You'd figure that'd be enough to solve any housing squeeze, right? But here's the kicker: vacancy rates are stuck at 11.8% — way over the national mean of 7.9%. Discounts like two...